• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2006 Fiscal Year Final Research Report Summary

Comprehensive analysis of oncogenic transcriptional factor Evi-1.

Research Project

Project/Area Number 17390273
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionThe University of Tokyo

Principal Investigator

KUROKAWA Mineo  The University of Tokyo, Faculty of Medicine, Professor, 医学部附属病院, 教授 (80312320)

Co-Investigator(Kenkyū-buntansha) HANGAISHI Akira  The University of Tokyo, Faculty of Medicine, Lecturer, 医学部附属病院, 特任講師 (20344450)
IZUTSU Koji  The University of Tokyo, Faculty of Medicine, Assistant, 医学部附属病院, 助手 (30361471)
GOYAMA Susumu  The University of Tokyo, Faculty of Medicine, Research Associate, 医学部附属病院, 医員 (80431849)
Project Period (FY) 2005 – 2006
KeywordsEvi-1 / leukemia / isoform / oligomerization / knockout mice / hematopoietic stem cell
Research Abstract

Evi-1 is a member of the SET/PR domain family of transcription factors whose inappropriate expression leads to leukemic transformation. Two distinct alternative forms, Evi-1a and Evi-1c, are generated from the Evi-1 gene. Although Evi-1a (PR-absent form) is widely recognized as an oncoprotein, a role for Evi-1c (PR-containing form) in leukemogenesis has not been elucidated. In this study, we showed that Evi-la forms homo-oligomers while Evi-1c exclusively exists as a monomer. Remarkably, Evi-1c has lost the ability to interact with CtBP, and to repress TGF-β signaling. These results indicate that oligomeraization contributes to the oncogenic potential of Evi-1.
Next, We created Evi-1 mutant mice to investigate the in vivo role of Evi-1 in hematopoiesis and leukemogenesis. Using these mice, we showed that Evi-1 regulates proliferative capacity of hematopoietic stem cells in a dose-dependent manner both during embryogenesis and in adults. In contrast, Evi-1 is dispensable for blood cell lineage commitment. We further demonstrated that disruption of Evi-1 in leukemic cells transformed by MLL/ENL or E2A/HLF leads to significant loss of their proliferative activity. These results suggest that Evi-1 is a critical regulator for the proliferation of normal and leukemic cells.

  • Research Products

    (12 results)

All 2007 2006 2005 Other

All Journal Article (12 results)

  • [Journal Article] A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive B-cell lymphoma : a single-institution study.2007

    • Author(s)
      Nitta E, Izutsu K, Sato T, Ota Y, Takeuchi K, Kamijo A, Takahashi K, Oshima K, Kanda Y, Chiba S, Motokura T, Kurokawa M
    • Journal Title

      Annals of Oncology 18・2

      Pages: 364-369

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.2007

    • Author(s)
      Kako S, Kanda Y, Sato T, Goyama S, Noda N, Shoda E, Oshima K, Inoue M, Izutsu K, Watanabe T, Motokura T, Chiba S, Fukayama M, Kurokawa M
    • Journal Title

      American Journal of Hematology 82・5

      Pages: 386-390

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] A high incidence of late-onset neutropenia following rituximab-containing chemotherapy as a primary treatment of CD20-positive β-cell lymphoma : a single-institution study.2007

    • Author(s)
      Nitta E, Izutsu K, Sato T, Ota Y, Takeuchi K, Kamijo A, Takahashi K, Oshima K, Kanda Y, Chiba S, Motokura T, Kurokawa M.
    • Journal Title

      Annals of Oncology. 18(2)

      Pages: 364-369

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.2007

    • Author(s)
      Kako S, Kanda Y, Sato T, Goyama S, Noda N, Shoda E, Oshima K, Inoue M, Izutsu K, Watanabe T, Motokura T, Chiba S, Fukayama M, Kurokawa M.
    • Journal Title

      American Journal of Hematology. 82(5)

      Pages: 386-390

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] AML1/Runx1 as a versatile regulator of hematopoiesis : regulation of its function and a role in adult hematopoiesis.2006

    • Author(s)
      Kurokawa M.
    • Journal Title

      International Journal of Hematology 84・2

      Pages: 136-142

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] AML1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis.2006

    • Author(s)
      Nakagawa M, Ichikawa M, Kumano K, Goyama S, Kawazu M, Asai T, Ogawa S, Kurokawa M, Chiba S
    • Journal Title

      Blood 108・10

      Pages: 3329-3334

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] AML1/Runx1 as a versatile regulator of hematopoiesis : regulation of its function and a role in adult hematopoiesis.2006

    • Author(s)
      Kurokawa M.
    • Journal Title

      Journal of Hematology. 84(2)

      Pages: 136-142

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] AMI1/Runx1 rescues Notch1-null mutation-induced deficiency of para-aortic splanchnopleural hematopoiesis.2006

    • Author(s)
      Nakagawa M, Ichikawa M, Kumano K, Goyama S, Kawazu M, Asai T, Ogawa S, Kurokawa M, Chiba S.
    • Journal Title

      Blood. 108(10)

      Pages: 3329-3334

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP2005

    • Author(s)
      Nitta E, Izutsu K, Yamaguchi Y, Imai Y, Ogawa S, Chiba S, Kurokawa M, Hirai H
    • Journal Title

      Oncogene 24・40

      Pages: 6165-6173

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] Oligomerization of Evi-1 regulated by the PR domain contributes to recruitment of corepressor CtBP.2005

    • Author(s)
      Nitta E, Izutsu K, Yamaguchi Y, Imai Y, Ogawa S, Chiba S, Kurokawa M, Hirai H.
    • Journal Title

      Oncogene. 24(40)

      Pages: 6165-6173

    • Description
      「研究成果報告書概要(欧文)」より
  • [Journal Article] FDG-PET in T-cell and NK-cell neoplasms.

    • Author(s)
      Kako S, Izutsu K, Ohta Y, Minatani Y, Sugaya M, Momose T, Ohtomo K, Kanda Y, Chiba S, Motokura T, Kurokawa M
    • Journal Title

      Annals of Oncology (in press)

    • Description
      「研究成果報告書概要(和文)」より
  • [Journal Article] FDG-PET in T-cell and NK-cell neoplasms.

    • Author(s)
      Kako S, Izutsu K, Ohta Y, Minatani Y, Sugaya M, Momose T, Ohtomo K, Kanda Y, Chiba S, Motokura T, Kurokawa M.
    • Journal Title

      Annals of Oncology (in press)

    • Description
      「研究成果報告書概要(欧文)」より

URL: 

Published: 2008-05-27  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi